Related references
Note: Only part of the references are listed.The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele
Seema Patel et al.
JOURNAL OF IMMUNOLOGY (2017)
Induction of tumor regression by intratumoral STING agonists combined with anti-programmed death-L1 blocking antibody in a preclinical squamous cell carcinoma model
Shekhar K. Gadkaree et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
Silvia Cerboni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
Bridget Larkin et al.
JOURNAL OF IMMUNOLOGY (2017)
Sublingual targeting of STING with 3′3′-cGAMP promotes systemic and mucosal immunity against anthrax toxins
Tara L. Martin et al.
VACCINE (2017)
Absence of Specific Chlamydia trachomatis Inclusion Membrane Proteins Triggers Premature Inclusion Membrane Lysis and Host Cell Death
Mary M. Weber et al.
CELL REPORTS (2017)
Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway
Suruchi N. Schock et al.
CELL DEATH AND DIFFERENTIATION (2017)
Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells
Chih-Hang Anthony Tang et al.
CANCER RESEARCH (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents
Julie Gaston et al.
ONCOTARGET (2016)
STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria
Emily Spaulding et al.
PLOS PATHOGENS (2016)
STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease
Nicole Dobbs et al.
CELL HOST & MICROBE (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Ryan M. Young et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo
Steven M. Blaauboer et al.
ELIFE (2015)
Recognition of cytosolic DNA by cGAS and other STING-dependent sensors
Numana Bhat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
MPYS/STING-Mediated TNF-α, Not Type I IFN, Is Essential for the Mucosal Adjuvant Activity of (3′-5′)-Cyclic-Di-Guanosine-Monophosphate In Vivo
Steven M. Blaauboer et al.
JOURNAL OF IMMUNOLOGY (2014)
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
Andrea Ablasser et al.
NATURE (2013)
Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities
Peter M. Gray et al.
CELLULAR IMMUNOLOGY (2012)
MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP
Lei Jin et al.
JOURNAL OF IMMUNOLOGY (2011)
STING is a direct innate immune sensor of cyclic di-GMP
Dara L. Burdette et al.
NATURE (2011)
Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP
Gabriel Kristian Pedersen et al.
PLOS ONE (2011)
Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
Thomas Ebensen et al.
VACCINE (2011)
Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice
Abdullah S. Madhun et al.
VACCINE (2011)
XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells
Chih-Chi Andrew Hu et al.
EMBO JOURNAL (2009)
Murine B Cell Response to TLR7 Ligands Depends on an IFN-β Feedback Loop
Nathaniel M. Green et al.
JOURNAL OF IMMUNOLOGY (2009)
c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection
Dong-Liang Hu et al.
VACCINE (2009)
The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 Transcription Factor Activation
Bo Zhong et al.
IMMUNITY (2008)
MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals
Lei Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Christoph Mancao et al.
BLOOD (2007)
Bacterial c-di-GMP is an immunostimulatory molecule
David K. R. Karaolis et al.
JOURNAL OF IMMUNOLOGY (2007)
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties
Thomas Ebensen et al.
VACCINE (2007)
Testing gene function early in the B cell lineage in mb1-cre mice
E. Hobeika et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cyclic di-GMP as a second messenger
U Römling et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
C-di-GMP:: the dawning of a novel bacterial signalling system
U Römling et al.
MOLECULAR MICROBIOLOGY (2005)
Identification of genes involved in the switch between the smooth and rugose phenotypes of Vibrio cholerae
MH Rashid et al.
FEMS MICROBIOLOGY LETTERS (2003)
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
EA Leadbetter et al.
NATURE (2002)
IFN-α/β enhances BCR-dependent B cell responses
D Braun et al.
INTERNATIONAL IMMUNOLOGY (2002)
Share Paper
